Strong correlations among four measures of disease progression in Friedreich's ataxia

Mov Disord. 2018 Jul;33(6):1021-1022. doi: 10.1002/mds.27351. Epub 2018 Apr 6.

Authors

Harry J Saal¹, Frederic Heerinckx¹, Rezi Zawadzki², Omid Omidvar³, Marcus Kilpatrick⁴, Theresa Zesiewicz⁵

Affiliations

¹ Retrotope, Inc., Los Altos, California, USA.
² GISS Enterprises, Palo Alto, California, USA.
³ Collaborative Neuroscience Network, Long Beach, California, USA.
⁴ University of South Florida, Division of Exercise Science, Tampa, Florida, USA.
⁵ University of South Florida, Department of Neurology, Tampa, Florida, USA.

PMID: 29624733
DOI: 10.1002/mds.27351

No abstract available

Publication types

Letter

MeSH terms

Disease Progression*
Double-Blind Method
Friedreich Ataxia / diagnosis*
Friedreich Ataxia / drug therapy
Friedreich Ataxia / physiopathology*
Humans
Linoleic Acid / therapeutic use
Oxygen Consumption / drug effects
Walking / physiology
Workload

Substances

Linoleic Acid